Related references
Note: Only part of the references are listed.IgH partner breakpoint sequences provide evidence that AID initiates t(11;14) and t(8;14) chromosomal breaks in mantle cell and Burkitt lymphomas
Harvey A. Greisman et al.
BLOOD (2012)
Molecular pathogenesis of mantle cell lymphoma
Pedro Jares et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial
K. D. Boyd et al.
LEUKEMIA (2012)
A Modified Method for Whole Exome Resequencing from Minimal Amounts of Starting DNA
Iwanka Kozarewa et al.
PLOS ONE (2012)
The genetic architecture of multiple myeloma
Gareth J. Morgan et al.
NATURE REVIEWS CANCER (2012)
A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value
Brian A. Walker et al.
BLOOD (2010)
The t(14;20) is a poor prognostic factor in myeloma but is associated with long-term stable disease in monoclonal gammopathies of undetermined significance
Fiona M. Ross et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
MafB oncoprotein detected by immunohistochemistry as a highly sensitive and specific marker for the prognostic unfavorable t(14;20) (q32;q12) in multiple myeloma patients
Ev Stralen et al.
LEUKEMIA (2009)
Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma
Matthew W. Jenner et al.
BLOOD (2007)
Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma
David Gonzalez et al.
BLOOD (2007)
Large common fragile site genes and cancer
David I. Smith et al.
SEMINARS IN CANCER BIOLOGY (2007)
Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma
L. Chiecchio et al.
LEUKEMIA (2006)
Age has a profound effect on the incidence and significance of chromosome abnormalities in myeloma
FM Ross et al.
LEUKEMIA (2005)
The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB:: a molecular and genetic analysis of the chromosomal breakpoint
GR Boersma-Vreugdenhil et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease
J Orchard et al.
BLOOD (2003)
In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression
JJ Keats et al.
BLOOD (2003)
WWOX:: A candidate tumor suppressor gene involved in multiple tumor types
AJW Paige et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Chromosome translocations in multiple myeloma
PL Bergsagel et al.
ONCOGENE (2001)
Frequent chromosomal translocations induced by DNA double-strand breaks
C Richardson et al.
NATURE (2000)
Share Paper
